SRI vs VC vs THRM

For growth investors, Gentherm Incorporated (THRM) is the stronger pick with 2.

6% revenue growth year-over-year, versus -5. 2% for Stoneridge, Inc. (SRI). Visteon Corporation (VC) offers the better valuation at 15. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Stoneridge, Inc. (SRI) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Visteon Corporation (VC) is the cheapest at 15.

6x versus Gentherm Incorporated at 51. 5x. On forward P/E, Gentherm Incorporated is actually cheaper at 11. 6x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Visteon Corporation (VC) delivered a total return of -9.

4%, compared to -78. 7% for Stoneridge, Inc. (SRI). Over 10 years, the gap is even starker: VC returned +53. 7% versus SRI's -51. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Visteon Corporation (VC) is the lower-risk stock at 1.

14β versus Stoneridge, Inc. 's 2. 72β — meaning SRI is approximately 139% more volatile than VC relative to the S&P 500. On balance sheet safety, Visteon Corporation (VC) carries a lower debt/equity ratio of 33% versus 106% for Stoneridge, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Gentherm Incorporated (THRM) is pulling ahead at 2.

6% versus -5. 2% for Stoneridge, Inc. (SRI). On earnings-per-share growth, the picture is similar: Visteon Corporation grew EPS -25. 9% year-over-year, compared to -516. 7% for Stoneridge, Inc.. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Visteon Corporation (VC) is the more profitable company, earning 5.

3% net margin versus -11. 9% for Stoneridge, Inc. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VC leads at 8. 8% versus -2. 0% for SRI. At the gross margin level — before operating expenses — THRM leads at 23. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Gentherm Incorporated (THRM) trades at 11.

6x forward P/E versus 27. 2x for Stoneridge, Inc. — 15. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THRM: 18. 8% to $36. 67.

In this comparison, VC (0.

5% yield) pays a dividend. SRI, THRM do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Visteon Corporation (VC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

14)). Stoneridge, Inc. (SRI) carries a higher beta of 2. 72 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VC: +53. 7%, SRI: -51. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: SRI is a small-cap quality compounder stock; VC is a small-cap deep-value stock; THRM is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.